364
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The FACE Trial: Letrozole or Anastrozole as Initial Adjuvant Therapy?

, M.D. & , M.D.
Pages 14-18 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sunil Verma & Christian Jackisch. (2011) Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of age. Expert Review of Anticancer Therapy 11:2, pages 277-286.
Read now
William J. Gradishar. (2010) Adjuvant Endocrine Therapy for Early Breast Cancer: The Story So Far. Cancer Investigation 28:4, pages 433-442.
Read now
J Michael Dixon. (2008) Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer. Expert Review of Anticancer Therapy 8:3, pages 453-463.
Read now
Inge Schuster & Rita Bernhardt. (2007) Inhibition of Cytochromes P450: Existing and New Promising Therapeutic Targets. Drug Metabolism Reviews 39:2-3, pages 481-499.
Read now

Articles from other publishers (4)

Rishi Jain, Howard D. Strickler, Eugene Fine & Joseph A. Sparano. (2013) Clinical Studies Examining the Impact of Obesity on Breast Cancer Risk and Prognosis. Journal of Mammary Gland Biology and Neoplasia 18:3-4, pages 257-266.
Crossref
Rachel A. Freedman & Eric P. Winer. (2010) Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer. The Breast 19:2, pages 69-75.
Crossref
Rowan T. Chlebowski. (2008) Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer. Breast Cancer Research and Treatment 112:S1, pages 25-34.
Crossref
Christina I. Herold & Kimberly L. Blackwell. (2008) The impact of adjuvant endocrine therapy on reducing the risk of distant metastases in hormone-responsive breast cancer. The Breast 17, pages S15-S24.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.